Cyclooxygenase-2 preserves flow-mediated remodelling in old obese zucker rat mesenteric arteries

Cardiovascular Research

Volumn 86, Issue 3, 2010, Pages 516-525

  Belin De Chantemle, Eric J ^a   Vessires, Emilie ^a   Guihot, Anne Laure ^a   Toutain, Bertrand ^a   Loufrani, Laurent ^a   Henrion, Daniel ^a  

^a UNIVERSITÉ D'ANGERS   (France)

Author keywords

Ageing; Cyclooxygenase 2; Metabolic syndrome; Resistance arteries; Shear stress

Indexed keywords

ACETYLCHOLINE; CELECOXIB; CYCLOOXYGENASE 2; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDOMETACIN; PROSTANOID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY LIGATION; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME INHIBITION; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MALE; MESENTERIC ARTERY; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; VASCULAR ENDOTHELIUM; ZUCKER RAT;

ACETYLCHOLINE; AGE FACTORS; ANIMALS; BLOOD PRESSURE; CYCLOOXYGENASE 2; CYCLOOXYGENASE INHIBITORS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; HYPERTROPHY; INDOMETHACIN; MALE; MESENTERIC ARTERIES; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE TYPE III; NITROBENZENES; OBESITY; RATS; RATS, ZUCKER; REGIONAL BLOOD FLOW; SPLANCHNIC CIRCULATION; SULFONAMIDES; TIME FACTORS; VASCULAR RESISTANCE; VASODILATION; VASODILATOR AGENTS;

EID: 77952360763     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvp411     Document Type: Article

References (48)

1. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998;15:539-553.
2. Thomas GN, Chook P, Qiao M, Huang XS, Leong HC, Celermajer DS et al. Deleterious impact of 'high normal' glucose levels and other metabolic syndrome components on arterial endothelial function and intima-media thickness in apparently healthy Chinese subjects: the CATHAY study. Arterioscler Thromb Vasc Biol 2004;24: 739-743.
3. Iannuzzi A, De Michele M, Bond MG, Sacchetti L, Fortunato G, Salvatore F et al. Carotid artery remodeling in middle-aged women with the metabolic syndrome (from the 'Progetto ATENA' study). Am J Cardiol 2005;96:1162-1165.
4. Henrion D. Pressure and flow-dependent tone in resistance arteries. Role of myo-genic tone. Arch Mal Coeur Vaiss 2005;98:913-921.
5. Stepp DW, Pollock DM, Frisbee JC. Low-flow vascular remodeling in the metabolic syndrome X. Am J Physiol Heart Circ Physiol 2004;286:H964-H970.
6. Bouvet C, Belin de Chantemele E, Guihot AL, Vessieres E, Bocquet A, Dumont O et al. Flow-induced remodeling in resistance arteries from obese Zucker rats is associated with endothelial dysfunction. Hypertension 2007;50:248-254.
7. Pourageaud F, De Mey JG. Structural properties of rat mesenteric small arteries after 4-wk exposure to elevated or reduced blood flow. Am J Physiol 1997;273: H1699-H1706.
8. Belin de Chantemele EJ, Vessieres E, Guihot AL, Toutain B, Maquignau M, Loufrani L et al. Type 2 diabetes severely impairs structural and functional adaptation of rat resistance arteries to chronic changes in blood flow. Cardiovasc Res 2009;81: 788-796.
9. Briones AM, Montoya N, Giraldo J, Vila E. Ageing affects nitric oxide synthase, cyclooxygenase and oxidative stress enzymes expression differently in mesenteric resistance arteries. Auton Autacoid Pharmacol 2005;25:155-162.
10. Pinaud F, Bocquet A, Dumont O, Retailleau K, Baufreton C, Andriantsitohaina R et al. Paradoxical role of angiotensin II type 2 receptors in resistance arteries of old rats. Hypertension 2007;50:96-102.
11. Dumont O, Pinaud F, Guihot AL, Baufreton C, Loufrani L, Henrion D. Alteration in flow (shear stress)-induced remodelling in rat resistance arteries with aging: improvement by a treatment with hydralazine. Cardiovasc Res 2008;77:600-608.
12. Yan C, Huang A, Kaley G, Sun D. Chronic high blood flow potentiates shear stress-induced release of NO in arteries of aged rats. Am J Physiol Heart Circ Physiol 2007;293:H3105-H3110.
13. Castier Y, Brandes RP, Leseche G, Tedgui A, Lehoux S. p47phox-dependent NADPH oxidase regulates flow-induced vascular remodeling. Circ Res 2005;97:533-540.
14. Bakker EN, Pistea A, VanBavel E. Transglutaminases in vascular biology: relevance for vascular remodeling and atherosclerosis. J Vasc Res 2008;45:271-278.
15. Zanchi A, Delacretaz E, Taleb V, Gaillard R, Jeanrenaud B, Brunner HR et al. Endo-thelial function of the mesenteric arteriole and mechanical behaviour of the carotid artery in rats with insulin resistance and hypercholesterolaemia. J Hypertens 1995; 13:1463-1470.
16. Wong SL, Leung FP, Lau CW, Au CL, Yung LM, Yao X et al. Cyclooxygenase-2-derived prostaglandin F2alpha mediates endothelium-dependent contractions in the aortae of hamsters with increased impact during aging. Circ Res 2009;104: 228-235.
17. Ben Driss A, Devaux C, Henrion D, Duriez M, Thuillez C, Levy BI et al. Hemodynamic stresses induce endothelial dysfunction and remodeling of pulmonary artery in experimental compensated heart failure. Circulation 2000;101:2764-2770.
18. Matrougui K, Maclouf J, Levy BI, Henrion D. Impaired nitric oxide-and prostaglandin-mediated responses to flow in resistance arteries of hypertensive rats. Hypertension 1997;30:942-947.
19. Halpern W, Osol G, Coy GS. Mechanical behavior of pressurized in vitro prearteriolar vessels determined with a video system. Ann Biomed Eng 1984;12: 463-479.
20. Iglarz M, Matrougui K, Levy BI, Henrion D. Chronic blockade of endothelin ETA receptors improves flow dependent dilation in resistance arteries of hypertensive rats. Cardiovasc Res 1998;39:657-664.
21. Belin de Chantemele EJ, Vessieres E, Dumont O, Guihot AL, Toutain B, Loufrani L et al. Reactive oxygen species are necessary for high flow (shear stress)-induced diameter enlargement of rat resistance arteries. Microcirculation 2009;16:391-402.
22. Loufrani L, Matrougui K, Li Z, Levy BI, Lacolley P, Paulin D et al. Selective microvas-cular dysfunction in mice lacking the gene encoding for desmin. FASEB J 2002;16: 117-119.
23. Henrion D, Laher I, Laporte R, Bevan JA. Angiotensin II amplifies arterial contractile response to norepinephrine without increasing Ca\+\+ influx: role of protein kinase C. J Pharmacol Exp Ther 1992;261:835-840.
24. Dowell FJ, Henrion D, Duriez M, Michel JB. Vascular reactivity in mesenteric resistance arteries following chronic nitric oxide synthase inhibition in Wistar rats. Br J Pharmacol 1996;117:341-346.
25. Mulvany MJ, Halpern W. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res 1977;41:19-26.
26. Henrion D, Dowell FJ, Levy BI, Michel JB. In vitro alteration of aortic vascular reactivity in hypertension induced by chronic NG-nitro-L-arginine methyl ester. Hypertension 1996;28:361-366.
27. Belin de Chantemele EJ, Retailleau K, Pinaud F, Vessieres E, Bocquet A, Guihot AL et al. Notch3 is a major regulator of vascular tone in cerebral and tail resistance arteries. Arterioscler Thromb Vasc Biol 2008;28:2216-2224.
28. Pourageaud F, De Mey JG. Vasomotor responses in chronically hyperperfused and hypoperfused rat mesenteric arteries. Am J Physiol 1998;274:H1301-H1307.
29. McCaleb ML, Sredy J. Metabolic abnormalities of the hyperglycemic obese Zucker rat. Metabolism 1992;41:522-525.
30. Perticone F, Ceravolo R, Candigliota M, Ventura G, Iacopino S, Sinopoli F et al. Obesity and body fat distribution induce endothelial dysfunction by oxidative stress: protective effect of vitamin C. Diabetes 2001;50:159-165.
31. Arcaro G, Cretti A, Balzano S, Lechi A, Muggeo M, Bonora E et al. Insulin causes endothelial dysfunction in humans: sites and mechanisms. Circulation 2002;105: 576-582.
32. Steinberg HO, Chaker H, Leaming R, Johnson A, Brechtel G, Baron AD. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest 1996;97:2601-2610.
33. Fulton D, Harris MB, Kemp BE, Venema RC, Marrero MB, Stepp DW. Insulin resistance does not diminish eNOS expression, phosphorylation, or binding to HSP-90. Am J Physiol Heart Circ Physiol 2004;287:H2384-H2393.
34. Bohlen HG. Protein kinase betaII in Zucker obese rats compromises oxygen and flow-mediated regulation of nitric oxide formation. Am J Physiol Heart Circ Physiol 2004;286:H492-H497.
35. Frisbee JC, Stepp DW. Impaired NO-dependent dilation of skeletal muscle arterioles in hypertensive diabetic obese Zucker rats. Am J Physiol Heart Circ Physiol 2001;281: H1304-H1311.
36. Bagi Z, Toth E, Koller A, Kaley G. Microvascular dysfunction after transient high glucose is caused by superoxide-dependent reduction in the bioavailability of NO and BH(4). Am J Physiol Heart Circ Physiol 2004;287:H626-H633.
37. Dey A, Williams RS, Pollock DM, Stepp DW, Newman JW, Hammock BD et al. Altered kidney CYP2C and cyclooxygenase-2 levels are associated with obesity-related albuminuria. Obes Res 2004;12:1278-1289.
38. Bagi Z, Erdei N, Toth A, Li W, Hintze TH, Koller A et al. Type 2 diabetic mice have increased arteriolar tone and blood pressure: enhanced release of COX-2-derived constrictor prostaglandins. Arterioscler Thromb Vasc Biol 2005;25: 1610-1616.
39. Szerafin T, Erdei N, Fulop T, Pasztor ET, Edes I, Koller A et al. Increased cyclooxygenase-2 expression and prostaglandin-mediated dilation in coronary arter-ioles of patients with diabetes mellitus. Circ Res 2006;99:e12-e17.
40. Nacci C, Tarquinio M, De Benedictis L, Mauro A, Zigrino A, Carratu MR et al. Endo-thelial dysfunction in mice with streptozotocin-induced type 1 diabetes is opposed by compensatory overexpression of cyclooxygenase-2 in the vasculature. Endocrinology 2009;150:849-861.
41. Fredenburgh LE, Liang OD, Macias AA, Polte TR, Liu X, Riascos DF et al. Absence of cyclooxygenase-2 exacerbates hypoxia-induced pulmonary hypertension and enhances contractility of vascular smooth muscle cells. Circulation 2008;117:2114-2122.
42. Rudic RD, Brinster D, Cheng Y, Fries S, Song WL, Austin S et al. COX-2-derived prostacyclin modulates vascular remodeling. Circ Res 2005;96:1240-1247.
43. Bakker EN, Matlung HL, Bonta P, de Vries CJ, van Rooijen N, Vanbavel E. Blood flow-dependent arterial remodelling is facilitated by inflammation but directed by vascular tone. Cardiovasc Res 2008;78:341-348.
44. Dumont O, Loufrani L, Henrion D. Key role of the NO-pathway and matrix metalloprotease-9 in high blood flow-induced remodeling of rat resistance arteries. Arterioscler Thromb Vasc Biol 2007;27:317-324.
45. Loufrani L, Retailleau K, Bocquet A, Dumont O, Danker K, Louis H et al. Key role of alpha(1)beta(1)-integrin in the activation of PI3-kinase-Akt by flow (shear stress) in resistance arteries. Am J Physiol Heart Circ Physiol 2008;294: H1906-H1913.
46. Gendron ME, Thorin-Trescases N, Villeneuve L, Thorin E. Aging associated with mild dyslipidemia reveals that COX-2 preserves dilation despite endothelial dysfunction. Am J Physiol Heart Circ Physiol 2007;292:H451-H458.
47. Bresalier RS, Sandler RS, Quan H, Bolognese JA, Oxenius B, Horgan K et al. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med 2005;352:1092-1102.
48. Fitzgerald GA. Prostaglandins: modulators of inflammation and cardiovascular risk. J Clin Rheumatol 2004;10:S12-S17.